Insight into the Functional and Structural Properties of 3‐Arylcoumarin as an Interesting Scaffold in Monoamine Oxidase B Inhibition
- 8 April 2014
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 9 (7) , 1488-1500
Abstract
The design, synthesis, pharmacological evaluation, and theoretical studies of a new series of halogenated 3‐arylcoumarins were carried out with the aim of finding new structural and biological features. This series displays several alkyl, hydroxy, halogen, and/or alkoxy groups in both benzene rings of the 3‐arylcoumarin scaffold. Most of the compounds studied show high affinity and selectivity for the human monoamine oxidase B (hMAO‐B) isoenzyme, with IC50 values in the low nanomolar and picomolar range. Most of the evaluated compounds display higher MAO‐B inhibitory activity and selectivity than selegiline (the reference compound). Coumarin 12 (3‐(3‐bromophenyl)‐6‐methylcoumarin) is the most active compound (IC50=134 pM), being 140‐fold more active than selegiline and showing the highest specificity for hMAO‐B. To better understand the structure–activity relationships, docking experiments were carried out on human monoamine oxidase (A and B) structures. Finally, the prediction of passive blood–brain partitioning, based on in silico derived physicochemical descriptors, was performed.Keywords
This publication has 50 references indexed in Scilit:
- Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivativesEuropean Journal of Medicinal Chemistry, 2011
- MAO-inhibitors in Parkinson's DiseaseExperimental Neurobiology, 2011
- MAO inhibitors: Risks, benefits, and loreCleveland Clinic Journal of Medicine, 2010
- Prediction of passive blood–brain partitioning: Straightforward and effective classification models based on in silico derived physicochemical descriptorsJournal of Molecular Graphics and Modelling, 2010
- Structural and Mechanistic Studies of Mofegiline Inhibition of Recombinant Human Monoamine Oxidase BJournal of Medicinal Chemistry, 2008
- Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitorsProceedings of the National Academy of Sciences, 2008
- Lipophilicity Plays a Major Role in Modulating the Inhibition of Monoamine Oxidase B by 7‐Substituted CoumarinsChemistry & Biodiversity, 2006
- Constitutive Phosphorylation of the Parkinson's Disease Associated α-SynucleinJournal of Biological Chemistry, 2000
- The molecular pharmacology of L-deprenylEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- AntidepressantsDrugs, 1989